AgingResearch.News

Pulmonary fibrosis

Disease4 papers4 findings

A human cohort links whole-blood MaGE-p16 to incident pulmonary fibrosis. In mouse models, Prkcq deletion, rapamycin, and Bapta-am each protect against lung fibrosis.

  • Humans1
  • Animals3

Interventions

3

Bapta-am

downin mice1

1 study
  1. Bapta-am protects against pulmonary fibrosis in mice.

    Animalslung

    Chelating intracellular calcium reduces fibroblast senescence and eases lung fibrosis · Biochimica et biophysica acta. General subjects · 30 Sep 2026

Bapta-am →

Rapamycin

downin mice1

1 study
  1. Rapamycin protects against pulmonary fibrosis in mice.

    Animalsbleomycin-induced pulmonary fibrosislung

    Rapamycin slows pulmonary fibrosis by reducing lung epithelial cell senescence in mice · Research Square · 28 Sep 2026 · Preprint

Rapamycin →

Prkcq deletion

downin mice1

1 study
  1. Prkcq deletion decreases pulmonary fibrosis in mice.

    Animalsbleomycin-inducedknockoutlung

    Protein kinase C θ deletion ameliorates bleomycin-induced pulmonary fibrosis via the improvement of SIRT1/AMPK signaling on autophagy and senescence · Iranian journal of basic medical sciences · 1 Jan 2026

Prkcq deletion →

Associations

1

MaGE-p16

upin humans1

1 study
  1. MaGE-p16 is associated with pulmonary fibrosis in humans.

    Humansincident diseasewhole bloodn = 18,859

    DNA methylation proxies of senescence markers track human disease and mortality · medRxiv · 1 Oct 2026 · Preprint

MaGE-p16 →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 3Oct 2026: 26